Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vγ9Vδ2 T cells
PLOS One · 06.04.2026 · 21 (4) · e0343925
DOI: 10.1371/journal.pone.0343925 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.04.2026. Verfasst von Christine M Qabar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant and Microbial Biology, University of California Berkeley, Berkeley California, United States of America. Hauptthemen laut MEDLINE: Synthetic Biology, Mycobacterium bovis, T-Lymphocytes, BCG Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of General Medical Sciences, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, U.S. Department of Energy, Office of Science, Biological and Environmental Research Program.
Abstract (Originalsprache)
There is an urgent need to develop a more efficacious anti-tuberculosis vaccine as the current live-attenuated vaccine strain BCG fails to prevent pulmonary infection in adults. In this study, we leverage a synthetic biology approach to engineer BCG to produce more (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), an intermediate of bacterial—but not host—isoprenoid biosynthesis via the methylerythritol phosphate (MEP) pathway. HMBPP strongly activates and expands Vγ9Vδ2 T cells, which are unique to higher-order primates and protect against Mycobacterium tuberculosis infection. BCG has been engineered to produce specific ligands and antigens to some success; in contrast, our strategy exploits a self-nonself recognition mechanism in the host via HMBPP sensing, which has not been attempted before. To inform the design of our recombinant strains, we performed synteny analyses of >63 mycobacterial species and found that isoprenoid biosynthetic genes are not operonic across all the 356 surveyed genomes, but some genes are frequently found in pairs. Thus, we generated synthetic loci with the goal of specifically overproducing HMBPP and tested the ability of these engineered strains to induce human Vγ9Vδ2 expansion in an in vitro stimulation assay. We found that BCG expressing a synthetic MEP locus significantly enhanced Vγ9Vδ2 T cell expansion over the wild-type vaccine strain, and overexpression of the HMBPP synthase GcpE alone potently induced Vγ9Vδ2 T cell expansion with no downregulation of other pathway genes. Together these engineered strains present two successful strategies to accumulate HMBPP and overcome feedback inhibition of the MEP pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plant and Microbial Biology, University of California Berkeley, Berkeley California, United States of America.
- Department of Molecular and Cell Biology, University of California Berkeley, Berkeley California, United States of America.
- Department of Bioengineering, University of California Berkeley, Berkeley California, United States of America.
- Department of Electrical Engineering and Computer Science, University of California Berkeley, Berkeley California, United States of America.
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Emeryville California, United States of America.
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
ORCID-Profile: Christine M Qabar, Lucas M Waldburger, Jeffery S Cox
Förderung
- National Institute of General Medical Sciences
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- U.S. Department of Energy, Office of Science, Biological and Environmental Research Program
- Irving H. Wiesenfeld Fellowship, Henry Wheeler Center for Emerging and Neglected Diseases
- Graduate Research Fellowship Program, U.S. National Science Foundation
Zitieren
APA
Qabar, C. M., Roberts, A. W., Waldburger, L. M., Baidoo, E. E. K., Turumtay, E. A., Keasling, J. D., Portnoy, D. A., & Cox, J. S. (2026). Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vγ9Vδ2 T cells. PLOS One, 21(4), e0343925. https://doi.org/10.1371/journal.pone.0343925
Vancouver
Qabar CM, Roberts AW, Waldburger LM, Baidoo EEK, Turumtay EA, Keasling JD, et al. Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vγ9Vδ2 T cells. PLOS One. 2026;21(4):e0343925. doi:10.1371/journal.pone.0343925
BibTeX
@article{Qabar2026,
author = {Qabar, Christine M and Roberts, Allison W and Waldburger, Lucas M and Baidoo, Edward E K and Turumtay, Emine Akyuz and Keasling, Jay D and Portnoy, Dan A and Cox, Jeffery S},
title = {Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vγ9Vδ2 T cells},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0343925},
doi = {10.1371/journal.pone.0343925}
}
EUVIMED